Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtered by market cap "Mega ≥$200B", profit streak "≥5 yr": 60 match(clear filters).

#	Ticker	Mkt Cap	Score▼	10Y ROE	Profit Streak	Net Debt/Eq	Gross Margin	Report	FY
1	Visa Inc. Class A V · US	$684B	95/100 Elite	35.7%low 18.2%	10 yr+	0.1×	81%	Visa Inc. Long-Term Business Owner ResearchMay 25, 2026 · Watch	FY2025
2	KLA Corporation KLAC · US	$239B	93/100 Elite	55.9%low 44.2%	10 yr+	0.2×	61%	KLA Corporation: A Deep Value Investment AnalysisMay 22, 2026 · Watch	FY2026
3	Kweichow Moutai Co Ltd 600519 · Shanghai	$236B	93/100 Elite	30.8%low 22.9%	10 yr+	Net cash	90%	Kweichow Moutai: A Long-Term Business Owner's PerspectiveMay 21, 2026 · Watch	FY2025
4	ASML Holding NV ADR ASML · US	$626B	92/100 Elite	36.5%low 15.9%	10 yr+	Net cash	49%	ASML Holding NV: A Long-Term Business Owner's PerspectiveMay 20, 2026 · Watch	FY2025
5	Applied Materials Inc AMAT · US	$403B	92/100 Elite	38.9%low 23.8%	10 yr+	Net cash	46%	Applied Materials Deep Value Investment ResearchMay 21, 2026 · Watch	FY2025
6	Roche Holding AG ROG · SW	$326B	92/100 Elite	39.6%low 26.1%	10 yr+	0.5×	72%	Roche Zen Horizon Framework Deep Dive: A Diagnostics and Pharma Giant Past the Patent Cliff, with a Fair Price and Debated GrowthJun 5, 2026 · Hold	FY2025
7	Microsoft Corporation MSFT · US	$3.5T	91/100 Elite	34.6%low 20.0%	10 yr+	0.1×	68%	Microsoft: Azure Demand Is Real and the Moat Is Intact, but 393 USD Already Prices a Clean Conversion of the 190 Billion USD Capex WaveJul 29, 2026 · Hold	FY2026
8	Lam Research Corp LRCX · US	$367B	90/100 Elite	48.3%low 24.3%	10 yr+	Net cash	47%	Lam Research from a Long-Term Business Owner's PerspectiveMay 22, 2026 · Watch	FY2026
9	American Express Company AXP · US	$227B	89/100 Elite	27.8%low 13.6%	10 yr+	0.3×	87%	American Express Closed-Loop Payments Platform ResearchMay 23, 2026 · Watch	FY2025
10	Arista Networks ANET · US	$227B	88/100 Elite	24.1%low 15.3%	10 yr+	Net cash	64%	Arista Networks: A Long-Term Study of the Data Center Switching LeaderMay 23, 2026 · Watch	FY2025
11	LOréal S.A. OR · Paris	$222B	88/100 Elite	16.5%low 12.3%	10 yr+	0.1×	73%	L’Oréal: Record First-Half Margins and a Broad-Based Recovery, but 30 Times Earnings Already Prices In the China and Gucci UpsideAug 5, 2026 · Hold	FY2025
12	Novo Nordisk A/S NOVO-B · CO	$210B	88/100 Elite	59.3%low 52.8%	10 yr+	0.5×	84%	Novo Nordisk: A Long-Term Owner's PerspectiveMay 17, 2026 · Watch	FY2025
13	Cisco Systems Inc CSCO · US	$457B	87/100 Elite	22.4%low 0.3%	10 yr+	0.3×	63%	Cisco Systems: A Value-Investing Deep DiveMay 22, 2026 · Watch	FY2025
14	Costco Wholesale Corp COST · US	$422B	87/100 Elite	25.4%low 19.5%	10 yr+	Net cash	13%	Costco: A Deep-Dive Value Investing AnalysisMay 21, 2026 · Watch	FY2025
15	Mastercard Inc MA · US	$502B	86/100 Elite	60.0%low 60.0%	10 yr+	1.0×	77%	Mastercard Deep Value Investment ResearchMay 25, 2026 · Watch	FY2025
16	Alphabet Inc Class C GOOG · US	$4.4T	85/100 Elite	21.7%low 8.3%	10 yr+	Net cash	57%	Alphabet: Search and Cloud Are Both Accelerating, but a 200 Billion Dollar Build Has Turned Free Cash Flow Negative and 333.68 Dollars Already Prices In the Base CaseJul 31, 2026 · Hold	FY2025
17	Meta Platforms Inc. META · US	$1.4T	84/100 Elite	24.3%low 17.3%	10 yr+	0.0×	82%	Meta Platforms: Revenue Grew 28% While Free Cash Flow Fell to 784 Million Dollars, and 556.71 Dollars Buys the Base Case With No Margin of SafetyAug 1, 2026 · Hold	FY2025
18	UnitedHealth Group Incorporated UNH · US	$376B	84/100 Elite	21.4%low 12.8%	10 yr+	0.5×	23%	UnitedHealth Group (UNH): A Deep-Dive Value Investing StudyMay 25, 2026 · Watch	FY2025
19	Procter & Gamble Company PG · US	$335B	84/100 Elite	26.6%low 8.3%	10 yr+	0.4×	50%	P&G Deep-Dive Value Research ReportMay 25, 2026 · Watch	FY2026
20	Apple Inc. AAPL · US	$4.5T	83/100 Elite	54.7%low 35.6%	10 yr+	0.8×	41%	Apple Inc.: Strip Out the Tariff Refunds and the 50.1% Margin Becomes 48.1%, While 308.91 Dollars Earns Less Than the Ten-Year TreasuryAug 1, 2026 · Hold	FY2025
21	LVMH Moët Hennessy - Louis Vuitton MC · Paris	$253B	83/100 Elite	19.2%low 12.1%	10 yr+	0.3×	67%	—	FY2025
22	Taiwan Semiconductor Manufacturing TSM · US	$2.1T	82/100 Elite	26.3%low 21.8%	10 yr+	Net cash	53%	TSMC: Earnings Have Outrun the Share Price to a 28.1x Trailing Multiple, but a Limit-Up Close at NT$2,425 Leaves Only a Limited Margin of SafetyJul 31, 2026 · Hold	FY2025
23	Johnson & Johnson JNJ · US	$618B	82/100 Elite	25.5%low 2.2%	10 yr+	0.3×	69%	Johnson & Johnson Deep Value Analysis: A Good Company Is Not CheapMay 25, 2026 · Watch	FY2025
24	Tencent Holdings Ltd 0700 · HK	$548B	82/100 Elite	21.1%low 13.2%	10 yr+	Net cash	48%	Tencent Holdings: A Deep Research StudyMay 28, 2026 · Cautious Buy	FY2025
25	Texas Instruments Incorporated TXN · US	$252B	82/100 Elite	46.2%low 28.4%	10 yr+	0.6×	63%	Texas Instruments Analog and Embedded Processors ResearchMay 23, 2026 · Watch	FY2025
26	NVIDIA Corporation NVDA · US	$4.9T	81/100 Elite	39.9%low 19.8%	10 yr+	Net cash	64%	NVIDIA: Demand Has Broadened Beyond the Hyperscalers, but Its Funding Base Has Not, and 197 USD Already Prices Continued ExcellenceJul 29, 2026 · Hold	FY2026
27	Nestle S.A. NESN · SW	$265B	80/100 Elite	23.7%low 11.7%	10 yr+	1.6×	48%	—	FY2025
28	The Coca-Cola Company KO · US	$377B	79/100 Strong	36.8%low 7.3%	10 yr+	1.0×	61%	Coca-Cola Deep Value Investment ResearchMay 25, 2026 · Watch	FY2025
29	The Home Depot Inc HD · US	$337B	78/100 Strong	60.0%low 60.0%	10 yr+	5.0×	34%	The Home Depot: A Value Investing Deep DiveMay 25, 2026 · Watch	FY2026
30	Novartis AG NOVN · SW	$306B	78/100 Strong	20.9%low 9.0%	10 yr+	0.6×	71%	Novartis (NVS) Zen Horizon Research ReportJun 8, 2026 · Hold	FY2025
31	SAP SE ADR SAP · US	$231B	77/100 Strong	12.6%low 5.7%	10 yr+	Net cash	71%	SAP: A High-Quality Incumbent Late in Its Cloud Migration, Now Priced for Proof Rather Than PossibilityJun 26, 2026 · Hold	FY2025
32	Philip Morris International Inc PM · US	$297B	76/100 Strong	49.2%^‡low 24.0%	10 yr+	—	60%	Philip Morris International: In-Depth Value Investment ResearchMay 25, 2026 · Watch	FY2025
33	Netflix Inc NFLX · US	$299B	74/100 Strong	25.2%low 7.0%	10 yr+	0.2×	40%	Netflix: A Long-Term Business Owner's PerspectiveMay 22, 2026 · Watch	FY2025
34	AbbVie Inc ABBV · US	$443B	73/100 Strong	54.6%low 35.2%	10 yr+	—	71%	AbbVie: In-Depth Research from a Long-Term Business Owner's PerspectiveMay 21, 2026 · Watch	FY2025
35	Merck & Company Inc MRK · US	$307B	71/100 Strong	24.4%low 1.0%	10 yr+	0.7×	70%	Merck & Co.: KEYTRUDA and QLEX Generated 50.4% of Second-Quarter Revenue While Subcutaneous Sales Rose to 463 Million Dollars Before the 2028 Patent CliffAug 5, 2026 · Hold	FY2025
36	International Business Machines IBM · US	$211B	71/100 Strong	34.1%low 7.5%	10 yr+	1.6×	52%	IBM Long-Term Owner's Perspective ResearchMay 25, 2026 · Watch	FY2025
37	MediaTek Inc 2454 · Taiwan	$226B	70/100 Strong	17.2%low 7.4%	10 yr+	Net cash	41%	MediaTek (2454.TW) Zen Horizon Framework Deep-Dive ResearchJun 9, 2026 · Watch	FY2025
38	Walmart Inc. WMT · US	$885B	69/100 Strong	16.0%low 8.4%	10 yr+	0.6×	25%	Walmart Research from a Long-Term Owner's PerspectiveMay 23, 2026 · Watch	FY2026
39	Thermo Fisher Scientific Inc TMO · US	$213B	69/100 Strong	13.3%low 8.8%	10 yr+	0.5×	44%	Thermo Fisher: A Long-Term Owner's PerspectiveMay 25, 2026 · Watch	FY2025
40	Morgan Stanley MS · US	$331B	68/100 Strong	11.1%low 7.9%	10 yr+	Net cash	77%	Morgan Stanley Deep Value Investment Research ReportMay 25, 2026 · Watch	FY2025
41	Amgen Inc AMGN · US	$208B	67/100 Strong	51.4%low 7.8%	10 yr+	5.3×	76%	Amgen Inc. Deep-Dive Value Investing AnalysisMay 21, 2026 · Watch	FY2025
42	Oracle Corporation ORCL · US	$374B	65/100 Strong	46.3%low 7.8%	10 yr+	2.9×	76%	Oracle CorporationJul 28, 2026 · Hold	FY2026
43	AstraZeneca PLC AZN · US	$279B	64/100 Medium	15.4%low 0.3%	10 yr+	0.5×	78%	AstraZeneca: A Deep DiveJun 15, 2026 · Hold	FY2025
44	AstraZeneca PLC AZN · LSE	$249B	64/100 Medium	15.3%low 0.3%	10 yr+	0.5×	72%	—	FY2025
45	Broadcom Inc AVGO · US	$1.9T	63/100 Medium	24.2%low -7.9%	9 yr	0.6×	58%	Broadcom: AI Revenue Grew 143% to 10.8 Billion Dollars, but 389.28 Dollars Buys the Base Case at a 1.30% Owner-Earnings Yield Against 4.74% TreasuriesAug 1, 2026 · Hold	FY2025
46	Siemens AG ADR SIEGY · US	$249B	63/100 Medium	13.4%low 7.6%	10 yr+	0.6×	35%	Siemens AG (SIE.XETRA) Zen Horizon Research ReportJun 9, 2026 · Watch	FY2025
47	Contemporary Amperex Technology Co., Limite 3750 · HK	$380B	62/100 Medium	16.7%low 8.7%	10 yr+	Net cash	29%	CATL: A Zen Horizon Framework Deep DiveJun 4, 2026 · Cautious Buy	FY2025
48	BHP Group Limited BHP · LSE	$202B	62/100 Medium	18.8%low -12.0%	9 yr	0.3×	72%	—	FY2025
49	Caterpillar Inc CAT · US	$375B	60/100 Medium	34.1%low -0.5%	9 yr	1.6×	31%	Caterpillar Long-Term Value Investment AnalysisMay 24, 2026 · Watch	FY2025
50	Arm Holdings plc American Depositary Shares ARM · US	$256B	59/100 Medium	11.3%low 5.8%	6 yr	Net cash	92%	Arm Holdings: A Deep-Dive Value AnalysisMay 21, 2026 · Watch	FY2026
51	Eli Lilly and Company LLY · US	$1.0T	58/100 Medium	45.5%low -1.8%	8 yr	1.3×	78%	Eli Lilly Deep Value Research: A Great Company at Too High a PriceMay 25, 2026 · Watch	FY2025
52	Samsung Electronics Co Ltd 005930 · Korea	$1.7T	57/100 Medium	12.1%low 4.1%	10 yr+	Net cash	38%	Samsung Electronics: A Long-Term Owner's PerspectiveMay 22, 2026 · Watch	FY2025
53	Dell Technologies Inc DELL · US	$262B	57/100 Medium	20.6%^‡low -4.7%	7 yr	—	23%	Dell Technologies Deep Value ResearchMay 25, 2026 · Watch	FY2026
54	Goldman Sachs Group Inc GS · US	$309B	55/100 Medium	10.7%low 5.2%	10 yr+	Net cash	65%	Goldman Sachs Group Deep Value Investing AnalysisMay 25, 2026 · Watch	FY2025
55	CNOOC Limited 600938 · Shanghai	$215B	52/100 Medium	12.9%low 0.2%	10 yr+	Net cash	74%	—	FY2025
56	Linde plc Ordinary Shares LIN · US	$221B	48/100 Weak	13.9%low 4.7%	10 yr+	0.6×	32%	In-Depth Value Investment Analysis of Linde plcMay 22, 2026 · Watch	FY2025
57	RTX Corporation RTX · US	$290B	38/100 Weak	9.2%low -4.9%	5 yr	0.5×	21%	RTX Corporation: A Long-Term Value StudyMay 25, 2026 · Watch	FY2025
58	Shell PLC ADR SHEL · US	$252B	27/100 Poor	7.9%low -14.0%	5 yr	0.4×	11%	—	FY2025
59	Shell plc SHEL · LSE	$238B	27/100 Poor	7.9%low -14.0%	5 yr	0.4×	11%	—	FY2025
60	Shell PLC SHELL · Amsterdam	$237B	27/100 Poor	7.9%low -13.9%	5 yr	0.4×	11%	—	FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.